Revolutionize Gut Health with Akkermansia muciniphila from Creative Enzymes [PRBT-101] - 코아사이언스

Akkermansia muciniphila Freeze-drying Powder

Cat.# PRBT-101 / Size: inquire

 

Description

Akkermansia muciniphila is an oval, gram-negative, strictly anaerobic bacterium that is a commensal in the human gut. This bacterium is immobile and does not form spores. Akkermansia muciniphila was first isolated from the human gut in 2004 and has been found in both the small and large intestines, with particularly high levels in the cecum, where most of the mucin is produced.A. muciniphila comprises 3% to 5% of the gut microbiota of humans and other mammals. In addition, A. muciniphila has been detected in breast milk and mammary tissue of lactating women, where it utilizes oligosaccharides in breast milk as a source of energy, carbon, and nitrogen. This bacterium is vertically transmitted from breast milk to infants and plays a role in the development of the gut microbiota in early infancy (around 1 month), with a significant increase in abundance in adulthood. Pooled analyses performed on the global dataset showed that A. muciniphila was present in 77.73% of the evaluated cohorts globally and in 81.81% of the cohorts from Western populations.

 

 

Learn More.

​

Product Information

Product Name	Akkermansia muciniphila Freeze-drying Powder
Cat No.	PRBT-101
Source	Human
Species	Akkermansia muciniphila
Appearance	Off-white to beige powder
Total number of living bacteria	≥2.0 x1011 TFU/g
Moisture	≤5.0%
Shelf life	24 Months
Storage	Sealed, dark, dry, in a cool place

Applications

●	Gut health: Akkermansia muciniphila is a beneficial bacteria that can help maintain a healthy gut microbiome by promoting the growth of other beneficial bacteria and improving gut barrier function.
●	Immune system support: Some research suggests that Akkermansia muciniphila may play a role in modulating the immune system and reducing inflammation, making it potentially beneficial for immune system support.
●	Treatment of obesity and related metabolic disorders: Akkermansia muciniphila has been shown to improve metabolic health and decrease inflammation, making it a potential treatment for obesity, type 2 diabetes, and other metabolic disorders.
●	Brain health: Emerging research suggests that the gut-brain connection may be influenced by the gut microbiome, including Akkermansia muciniphila. Some studies have suggested that this bacteria may have potential benefits for brain health and cognitive function.
●	Cancer prevention: Some research suggests that Akkermansia muciniphila may have potential anti-cancer effects and could play a role in cancer prevention, particularly in gastrointestinal cancers.

Creative Enzymes also provides other probiotics for research or industry use.

 

* 본 상품은 오직 연구용으로만 사용 가능합니다. 인체 및 제품화에 사용하실 수 없습니다.

코아사이언스 coresciences creative-enzymes korea 한국 효소 단백질 Zymogen 자이모겐  치모겐 효소원 proenzyme 불활성인 효소 전구체 precursor coenzyme 코엔자임 기질 substrate 억제제 inhibitor